Literature DB >> 3136117

Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.

Y Tabata1, K Uno, Y Ikada, S Muramatsu.   

Abstract

Gelatin microspheres containing recombinant human interferon alpha A/D (A/D-IFN) (IFN-microspheres) potentiated the antitumor activity of mouse peritoneal macrophages (M phi) much more efficiently than free A/D-IFN. M phi acquired the inhibitory activity on tumor cell growth by the ingestion of IFN-microspheres without the aid of lipopolysaccharide (LPS), though LPS was required as a second signal for activating M phi primed with free IFN. The IFN-microspheres were much more efficient than free IFN plus LPS in respect of the IFN amount and the time required for M phi activation. Furthermore, M phi pretreated with the IFN-microspheres maintained their activated state for a much longer period than those pretreated with free A/D-IFN plus LPS. A monoclonal anti-IFN-alpha A antibody, which was capable of neutralizing A/D-IFN, did not interfere with the M phi activation by the IFN-microspheres. Even human IFN-alpha A was effective in activating murine M phi similarly to A/D-IFN, when given in the form of IFN-microspheres, though human IFN-alpha A in the free form was ineffective. These results argue that the mechanism of M phi activation by the IFN-microspheres is different from that by free IFN.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136117      PMCID: PMC5917552          DOI: 10.1111/j.1349-7006.1988.tb00034.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  An application of water-in-oil and gelatin-microsphere-in-oil emulsions to specific delivery of anticancer agent into stomach lymphatics.

Authors:  M Hashida; Y Takahashi; S Muranishi; H Sezaki
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

2.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

3.  Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.

Authors:  J B Hibbs
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Defective tumoricidal capacity of macrophages from C3H/HeJ mice.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.

Authors:  M J Brunda; D Rosenbaum; L Stern
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

6.  Antitumor and antimetastatic activities of human recombinant interferon alpha A/D.

Authors:  J Nishimura; K Mitsui; T Ishikawa; Y Tanaka; R Yamamoto; Y Suhara; H Ishitsuka
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

7.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Authors:  T Barlozzari; J Leonhardt; R H Wiltrout; R B Herberman; C W Reynolds
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.

Authors:  W C Koff; W E Fogler; J Gutterman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres.

Authors:  Y Tabata; Y Ikada
Journal:  J Pharm Pharmacol       Date:  1987-09       Impact factor: 3.765

10.  Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.

Authors:  W F Doe; P M Henson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  5 in total

1.  Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma.

Authors:  Tetsuya Toyama; Norihisa Nitta; Shinichi Ohta; Toyohiko Tanaka; Yukihiro Nagatani; Masashi Takahashi; Kiyoshi Murata; Hisanori Shiomi; Shigeyuki Naka; Yoshimasa Kurumi; Tohru Tani; Yasuhiko Tabata
Journal:  Jpn J Radiol       Date:  2011-12-17       Impact factor: 2.374

2.  Synthesis of gelatin microspheres containing interferon.

Authors:  Y Tabata; Y Ikada
Journal:  Pharm Res       Date:  1989-05       Impact factor: 4.200

3.  Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice.

Authors:  R Yoshida; O Takikawa; T Oku; A Habara-Ohkubo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine tumor cell growth.

Authors:  Y Tabata; K Uno; S Muramatsu; Y Ikada
Journal:  Jpn J Cancer Res       Date:  1989-04

5.  Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model.

Authors:  Shinichi Ohta; Norihisa Nitta; Masashi Takahashi; Kiyoshi Murata; Yasuhiko Tabata
Journal:  Korean J Radiol       Date:  2007 Sep-Oct       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.